Simplicia, Inc.
PrivateLast Round
Seed Round
Aug 13, 2026
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Simplicia, Inc. is a biotechnology company that provides an AI-native drug discovery platform for identifying therapeutic candidates from historical medical evidence.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, NLP & Conversational AI
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Simplicia, Inc. Comparables
Compare Simplicia, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Montai Health | 82% | |
| Pangea Bio | 82% | |
| Novogaia | 78% | |
Simplicia, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Aug 13, 2026 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 13, 2026
$600K Seed Round raised.
Simplicia, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Simplicia, Inc.'s valuation, stock price, and market status.